Prevego Healthcare & Research Profile
Key Indicators
- Authorised Capital ₹ 50.00 K
as on 16-11-2024
- Paid Up Capital ₹ 50.00 K
as on 16-11-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 16-11-2024
- Revenue 107.21%
(FY 2023)
- Profit 152.89%
(FY 2023)
- Ebitda 158.37%
(FY 2023)
- Net Worth 162.56%
(FY 2023)
- Total Assets 241.03%
(FY 2023)
About Prevego Healthcare & Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 K and a paid-up capital of Rs 50.00 K .
The company currently has active open charges totaling ₹5.00 Cr.
Brijesh Singh, Ketan Shah, Hemant Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC309271
- Company No.
309271
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Prevego Healthcare & Research?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ketan Shah  | Additional Director | 18-Jun-2019 | Current |
| Brijesh Singh | Director | 11-May-2018 | Current |
| Hemant Shah | Director | 11-May-2018 | Current |
| Ritesh Suresh | Additional Director | 18-Jun-2019 | Current |
| Manoj Shah | Additional Director | 18-Jun-2019 | Current |
Financial Performance of Prevego Healthcare & Research.
Prevego Healthcare & Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 107.21% increase. The company also saw a substantial improvement in profitability, with a 152.89% increase in profit. The company's net worth Soared by an impressive increase of 162.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prevego Healthcare & Research?
In 2023, Prevego Healthcare & Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 22 Sep 2022 | ₹5.00 Cr | Open |
How Many Employees Work at Prevego Healthcare & Research?
Unlock and access historical data on people associated with Prevego Healthcare & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prevego Healthcare & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prevego Healthcare & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
